Home > Qtrly Results > BLISS GVS PHARMA

BLISS GVS PHARMA
Quarterly Results Analysis [Sep2024]

BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Quarterly Results

Consolidated Sep2024
Audited
Jun2024
Audited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Revenues ₹218 Cr ₹184 Cr ₹198 Cr ₹201 Cr ₹212 Cr ₹160 Cr ₹185 Cr ₹206 Cr
Expenses ₹176 Cr ₹149 Cr ₹170 Cr ₹157 Cr ₹158 Cr ₹135 Cr ₹179 Cr ₹158 Cr
Operating Income ₹41 Cr ₹34 Cr ₹28 Cr ₹44 Cr ₹54 Cr ₹24 Cr ₹6 Cr ₹48 Cr
Other Income ₹5 Cr ₹4 Cr ₹6 Cr ₹5 Cr ₹13 Cr ₹5 Cr ₹3 Cr ₹6 Cr
Interest ₹4 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹5 Cr ₹1 Cr
Depreciation ₹7 Cr ₹7 Cr ₹7 Cr ₹7 Cr ₹6 Cr ₹6 Cr ₹5 Cr ₹5 Cr
Profit Before Tax ₹36 Cr ₹30 Cr ₹-4 Cr ₹40 Cr ₹59 Cr ₹22 Cr ₹-1 Cr ₹47 Cr
Profit After Tax ₹26 Cr ₹22 Cr ₹-5 Cr ₹29 Cr ₹43 Cr ₹14 Cr ₹3 Cr ₹30 Cr
EPS ₹2.31 ₹1.97 ₹-0.87 ₹2.64 ₹4.05 ₹1.41 ₹0.32 ₹2.68
Industry Peers & Returns1W1M1Y
BLISS GVS PHARMA 0.6% 26.7% 15.8%
SUN PHARMACEUTICAL INDUSTRIES 3.7% -3.2% 46.6%
CIPLA 0.6% -3.7% 26.7%
DR REDDYS LABORATORIES 1.9% -3.4% 5.8%
ZYDUS LIFESCIENCES 2.3% -3.4% 54%
DIVIS LABORATORIES 5.1% 6.1% 64%
MANKIND PHARMA 1.3% -3.5% 35.8%
TORRENT PHARMACEUTICALS 4.6% 4.4% 58%
LUPIN 5.1% -4.4% 62.5%

BLISS GVS PHARMA Quarterly Revenues

Revenues
Q-o-Q

18.53 %

Y-o-Y

2.74 %

Quarters Revenues % Change
Sep2024 ₹218 Cr
18.53
Jun2024 ₹184 Cr
-7.31
Mar2024 ₹198 Cr
-1.29
Dec2023 ₹201 Cr
-5.27
Sep2023 ₹212 Cr
32.82
Jun2023 ₹160 Cr
-13.67
Mar2023 ₹185 Cr
-10.18
Dec2022 ₹206 Cr -

BLISS GVS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

20.82 %

Y-o-Y

-23.71 %

Quarters Operating Profit % Change
Sep2024 ₹41 Cr
20.82
Jun2024 ₹34 Cr
21.11
Mar2024 ₹28 Cr
-35.12
Dec2023 ₹44 Cr
-19.63
Sep2023 ₹54 Cr
124.54
Jun2023 ₹24 Cr
287.97
Mar2023 ₹6 Cr
-86.91
Dec2022 ₹48 Cr -
Operating Margins
Q-o-Q

1.98 %

Y-o-Y

-25.72 %

Quarters Operating Margin% % Change
Sep2024 19.06%
1.98
Jun2024 18.69%
30.61
Mar2024 14.31%
-34.27
Dec2023 21.77%
-15.16
Sep2023 25.66%
69.04
Jun2023 15.18%
349.11
Mar2023 3.38%
-85.42
Dec2022 23.18% -

BLISS GVS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

16.23 %

Y-o-Y

-40.31 %

Quarters Profit After Tax % Change
Sep2024 ₹26 Cr
16.23
Jun2024 ₹22 Cr
Positive
Mar2024 ₹-5 Cr
Negative
Dec2023 ₹29 Cr
-32.46
Sep2023 ₹43 Cr
199.46
Jun2023 ₹14 Cr
314.59
Mar2023 ₹3 Cr
-88.36
Dec2022 ₹30 Cr -
PAT Margins
Q-o-Q

-1.99 %

Y-o-Y

-41.93 %

Quarters PAT Margin(%) % Change
Sep2024 11.8 %
-1.99
Jun2024 12.04 %
Positive
Mar2024 -2.48 %
Negative
Dec2023 14.48 %
-28.74
Sep2023 20.32 %
125.53
Jun2023 9.01 %
379.26
Mar2023 1.88 %
-87.02
Dec2022 14.48 % -

BLISS GVS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

17.26 %

Y-o-Y

-42.96 %

Quarters EPS % Change
Sep2024 ₹2.31
17.26
Jun2024 ₹1.97
Positive
Mar2024 ₹-0.87
Negative
Dec2023 ₹2.64
-34.81
Sep2023 ₹4.05
187.23
Jun2023 ₹1.41
340.63
Mar2023 ₹0.32
-88.06
Dec2022 ₹2.68 -

You may also like the below Video Courses